Design of a tumor-homing cell-penetrating peptide

Bioconjugate Chemistry

Volumn 19, Issue 1, 2008, Pages 70-75

  Myrberg, Helena ^a   Zhang, Lianglin ^b,c   Mäe, Maarja ^a   Langel, Ülo ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PENETRATING PEPTIDE; CHIMERIC PROTEIN; CHLORAMBUCIL; CYCLO(CYSTEINYLPROLYLGLYCYLPROLYLGLUTAMYLALANYLGLYCYLCYSTEINE); CYCLOPEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DESIGN; DRUG PENETRATION; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PEPTIDE SYNTHESIS; TUMOR XENOGRAFT;

MUS;

EID: 38949104405     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0701139     Document Type: Article

References (31)

1. Marsh, S., and McLeod, H. L. (2007) Pharmacogenetics and oncology treatment for breast cancer. Exp. Opin. Pharmacother. 8, 119-127.
2. Ruoslahti, E. (2002) Drug targeting to specific vascular sites. Drug Discovery Today 7, 1138-1143.
3. Ruoslahti, E. (2002) Specialization of tumour vasculature. Nat. Rev. Cancer. 2, 83-90.
4. Ruoslahti, E. (2004) Vascular zip codes in angiogenesis and metastasis. Biochem. Soc. Trans. 32, 397-402.
5. Zhang, L., Giraudo, E., Hoffman, J. A., Hanahan, D., and Ruoslahti, E. (2006) Lymphatic zip codes in premalignant lesions and tumors. Cancer Res. 66, 5696-5706.
6. Arap, W., Pasqualini, R., and Ruoslahti, E. (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377-380.
7. Hoffman, J. A., Giraudo, E., Singh, M., Zhang, L., Inoue, M., Porkka, K., Hanahan, D., and Ruoslahti, E. (2003) Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell 4, 383-391.
8. Essler, M., and Ruoslahti, E. (2002) Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc. Natl. Acad. Sci. U.S.A. 99, 2252-7.
9. Laakkonen, P., Porkka, K., Hoffman, J. A., and Ruoslahti, E. (2002) A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8, 751-755.
10. Lasch, J., Moschner, S., Sann, H., Zellmer, S., and Koelsch, R. (1998) Aminopeptidase P - a cell-surface antigen of endothelial and lymphoid cells: catalytic and immuno-histotopical evidences. Biol. Chem. 379, 705-709.
11. Gait, M. J. (2003) Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell. Mol. Life. Sci. 60, 844-853.
12. Rittner, K., Benavente, A., Bompard-Sorlet, A., Heitz, F., Divita, G., Brasseur, R., and Jacobs, E. (2002) New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol. Ther. 5, 104-114.
13. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315.
14. Järver, P., and Langel, , Ü. (2006) Cell-penetrating peptides - a brief introduction. Biochim. Biophys. Acta 1758, 260-263.
15. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590.
16. Thorén, P. E., Persson, D., Isakson, P., Goksor, M., Önfelt, A., and Norden, B. (2003) Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307, 100-107.
17. Faguet, G. B. (1994) Chronic lymphocytic leukemia: an updated review. J. Clin. Oncol. 12, 1974-1990.
18. Mattes, W. B., Hartley, J. A., and Kohn, K. W. (1986) DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Res. 14, 2971-2987.
19. Whiteside, G., Ferguson, L. R., Denny, W. A., and Weir, I. E. (2003) Mode of cell death induced in Chinese hamster cells by sequence-selective DNA minor groove binding nitrogen mustards: comparison with untargeted mustards and with Hoechst 33342. Oncol. Res. 13, 491-502.
20. Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., and Gottesman, M. M. (2006) Targeting multidrug resistance in cancer. Nat. Rev. Drug Discovery 5, 219-234.
21. Elmquist, A., Lindgren, M., Bartfai, T., and Langel, , Ü. (2001) VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell. Res. 269, 237-244.
22. Langel, , Ü., Land, T., and Bartfai, T. (1992) Design of chimeric peptide ligands to galanin receptors and substance P receptors. Int. J. Pept. Protein Res. 39, 516-522.
23. Tam, J. P., Wu, C., Liu, W., and Zhang, J. (1991) Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications. J. Am. Chem. Soc. 113, 6657-6662.
24. Soomets, U., Lindgren, M., Gallet, X., Hällbrink, M., Elmquist, A., Balaspiri, L., Zorko, M., Pooga, M., Brasseur, R., and Langel, , Ü. (2000) Deletion analogues of transportan. Biochim. Biophys. Acta 1467, 165-176.
25. Porkka, K., Laakkonen, P., Hoffman, J. A., Bernasconi, M., and Ruoslahti, E. (2002) A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 99, 7444-9.
26. Hällbrink, M., Kilk, K., Elmquist, A., Lundberg, P., Lindgren, M., Jiang, Y., Pooga, M., Soomets, U., and Langel, , Ü. (2005) Prediction of cell-penetrating peptides. Int. J. Peptide Res. Ther. 11, 249-259.
27. Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., Bredesen, D. E., and Pasqualini, R. (1999) Anticancer activity of targeted pro-apoptotic peptides. Nat. Med. 5, 1032-1038.
28. Chen, Y., Xu, X., Hong, S., Chen, J., Liu, N., Underhill, C. B., Creswell, K., and Zhang, L. (2001) RGD-Tachyplesin inhibits tumor growth. Cancer Res. 61, 2434-2438.
29. Eisenhut, M., Hull, W. E., Mohammed, A., Mier, W., Lay, D., Just, W., Gorgas, K., Lehmann, W. D., and Haberkorn, U. (2000) Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization. J. Med. Chem. 43, 3913-22.
30. Fotin-Mleczek, M., Fischer, R., and Brock, R. (2005) Endocytosis and cationic cell-penetrating peptides-a merger of concepts and methods. Curr. Pharm. Des. 11, 3613-3628.
31. Laakkonen, P., Akerman, M. E., Biliran, H., Yang, M., Ferrer, F., Karpanen, T., Hoffman, R. M., and Ruoslahti, E. (2004) Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc. Natl. Acad. Sci. U.S.A. 101, 9381-9386.